Skip to search formSkip to main contentSkip to account menu

XL119

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

becatecarin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Phase 1 study of XL119, a rebeccamycin analog, in patients with refractory hematologic malignancies
XL119 is a water‐soluble derivative of rebeccamycin with dose‐dependent myelosuppression as dose‐limiting toxicity in phase 1… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)